New York Times article today, June 17, 2013....states...

"Independent reviews of clinical trial data concluded that Infuse, a
bioengineered bone product, was not significantly better than a traditional bone graft, and that it might pose risks."

the article in full is in today's NY Times...

i am not expressing any opinion of my own...just quoting the article.

jess